MOREPEN LAB.
MOREPENLAB · NSE
119.31
-6.27 (-4.99%)
as of 29 Oct 2026 close
Open
119.31
High
119.31
Low
119.31
Prev close
125.58
52w high
150.70
07 Oct 2026
52w low
33.05
30 Mar 2026
VWAP
119.31
Delivery %
—
n/a
Volume 9.00 L · turnover ₹10.74 Cr · NSE bhavcopy (official close) · history since 04 Jan 2010
- ISIN
- INE083A01026
- Series
- BE
- Listed on NSE
- 24 Nov 1999
- Face value
- ₹2
- F&O
- No
Source: NSE equity master · as of 30 Oct 2026
Daily · NSE EOD
Quarterly results · Standalone · latest 30 Sept 2026
filed 27 Oct 2026, 06:38 pm IST| ₹ crore | Sept 26* |
|---|---|
| Revenue | 678 |
| Other income | 8 |
| Total expenses | 583 |
| Operating margin | 16.2% |
| Finance costs | 5 |
| Depreciation | 10 |
| Profit before tax | 104 |
| Tax | 26 |
| Net profit | 78 |
| Net margin | 11.5% |
| EPS (₹) | 1.42 |
Source and definitions
NSE financial-results filings (XBRL / integrated filing). Figures exactly as filed with NSE in the company's results, converted to ₹ crore from the filing's own rounding. Operating margin = (PBT + finance costs + depreciation − other income) ÷ revenue. Net margin = net profit ÷ revenue. * = unaudited quarter. Consolidated figures are shown when the company files them; otherwise standalone.
Coming next in fundamentals
Arrives in Phase 2. Nothing here is estimated or filled in — we only show data we have.
- P/E, P/B, EV/EBITDA, ROE, ROCE (needs balance sheet + market cap)
- FII / DII / mutual fund split (from shareholding XBRL)
- Peer comparison